234 related articles for article (PubMed ID: 8120035)
1. Disulfide bonds required to assemble functional von Willebrand factor multimers.
Dong Z; Thoma RS; Crimmins DL; McCourt DW; Tuley EA; Sadler JE
J Biol Chem; 1994 Mar; 269(9):6753-8. PubMed ID: 8120035
[TBL] [Abstract][Full Text] [Related]
2. Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib.
Rabinowitz I; Randi AM; Shindler KS; Tuley EA; Rustagi PK; Sadler JE
J Biol Chem; 1993 Sep; 268(27):20497-501. PubMed ID: 8376405
[TBL] [Abstract][Full Text] [Related]
3. Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly.
Mayadas TN; Wagner DD
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3531-5. PubMed ID: 1565649
[TBL] [Abstract][Full Text] [Related]
4. Human von Willebrand factor: a multivalent protein composed of identical subunits.
Chopek MW; Girma JP; Fujikawa K; Davie EW; Titani K
Biochemistry; 1986 Jun; 25(11):3146-55. PubMed ID: 3015199
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate.
Andrews RK; Gorman JJ; Booth WJ; Corino GL; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8326-36. PubMed ID: 2690940
[TBL] [Abstract][Full Text] [Related]
6. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites.
Mohri H; Yoshioka A; Zimmerman TS; Ruggeri ZM
J Biol Chem; 1989 Oct; 264(29):17361-7. PubMed ID: 2477370
[TBL] [Abstract][Full Text] [Related]
7. Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor.
Matsushita T; Sadler JE
J Biol Chem; 1995 Jun; 270(22):13406-14. PubMed ID: 7539426
[TBL] [Abstract][Full Text] [Related]
8. Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding.
Vicente V; Houghten RA; Ruggeri ZM
J Biol Chem; 1990 Jan; 265(1):274-80. PubMed ID: 2104618
[TBL] [Abstract][Full Text] [Related]
9. Two Cys residues essential for von Willebrand factor multimer assembly in the Golgi.
Purvis AR; Gross J; Dang LT; Huang RH; Kapadia M; Townsend RR; Sadler JE
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15647-52. PubMed ID: 17895385
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of the loss of intrachain- versus interchain-disulfide bonds in the cystine-knot domain of von Willebrand factor on the clinical phenotype of von Willebrand disease.
Tjernberg P; Vos HL; Spaargaren-van Riel CC; Luken BM; Voorberg J; Bertina RM; Eikenboom JC
Thromb Haemost; 2006 Dec; 96(6):717-24. PubMed ID: 17139364
[TBL] [Abstract][Full Text] [Related]
11. The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII.
Wise RJ; Dorner AJ; Krane M; Pittman DD; Kaufman RJ
J Biol Chem; 1991 Nov; 266(32):21948-55. PubMed ID: 1939217
[TBL] [Abstract][Full Text] [Related]
12. Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin.
Sixma JJ; Schiphorst ME; Verweij CL; Pannekoek H
Eur J Biochem; 1991 Mar; 196(2):369-75. PubMed ID: 1901037
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furin.
Fischer BE; Schlokat U; Mitterer A; Reiter M; Mundt W; Turecek PL; Schwarz HP; Dorner F
FEBS Lett; 1995 Nov; 375(3):259-62. PubMed ID: 7498512
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor.
Bockenstedt P; Greenberg JM; Handin RI
J Clin Invest; 1986 Mar; 77(3):743-9. PubMed ID: 2936763
[TBL] [Abstract][Full Text] [Related]
15. von Willebrand factor without the A2 domain is resistant to proteolysis.
Lankhof H; Damas C; Schiphorst ME; Ijsseldijk MJ; Bracke M; Furlan M; Tsai HM; de Groot PG; Sixma JJ; Vink T
Thromb Haemost; 1997 May; 77(5):1008-13. PubMed ID: 9184419
[TBL] [Abstract][Full Text] [Related]
16. Binding of factor VIII to von willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers.
Bendetowicz AV; Morris JA; Wise RJ; Gilbert GE; Kaufman RJ
Blood; 1998 Jul; 92(2):529-38. PubMed ID: 9657753
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of a recombinant glycoprotein Ib alpha polypeptide which inhibits von Willebrand factor binding to the platelet glycoprotein Ib-IX complex and to collagen.
Cruz MA; Petersen E; Turci SM; Handin RI
J Biol Chem; 1992 Jan; 267(2):1303-9. PubMed ID: 1730650
[TBL] [Abstract][Full Text] [Related]
18. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710
[TBL] [Abstract][Full Text] [Related]
19. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII.
Fischer BE; Kramer G; Mitterer A; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
Thromb Res; 1996 Oct; 84(1):55-66. PubMed ID: 8885147
[TBL] [Abstract][Full Text] [Related]
20. Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor.
Choi H; Aboulfatova K; Pownall HJ; Cook R; Dong JF
J Biol Chem; 2007 Dec; 282(49):35604-11. PubMed ID: 17925407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
